Company Performance Metrics
Bloomy is a Brazil-based healthtech company revolutionizing autism care through a fully verticalized model that combines proprietary clinics, in-house training, and a data-driven technology platform. The company addresses one of the fastest-growing cost drivers in Brazilian healthcare, autism therapies, now surpassing oncology in claims volume.
Bloomy already partners with the country’s largest health insurers, delivering scalable, compliant, and predictable care. Its platform integrates scheduling, biometric attendance, session recording, digital medical records, and automated billing (XML TISS), enabling real-time auditing, fraud prevention, and improved gross margins.
The founders previously built cuidar.me, scaling it from zero to R$120M in revenue in two years, and bring deep expertise in healthcare regulation, finance, and operations. With its B2B2C model, Bloomy secures long-term contracts with insurers, ensuring high revenue predictability and near-zero patient acquisition costs. Each clinic reaches full capacity in under 90 days, supported by a proven PMO-driven rollout playbook.
Backed by Kortex Ventures, Bloomy is positioned to consolidate a fragmented market (R$25.6B in 2023) by offering the first structured, scalable, and tech-enabled alternative for autism care in Brazil.
